GLAUKOS CORP.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 907
- Market Cap
- $7.4B
- Website
- http://www.glaukos.com
Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 53
- Registration Number
- NCT02873806
- Locations
- 🇦🇲
S.V. Malayan's Ophtalmology Centre, Yerevan, Armenia
Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication
- Conditions
- Interventions
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 57
- Registration Number
- NCT02868190
- Locations
- 🇦🇲
S.V. Malayan's Ophtalmology Centre, Yerevan, Armenia
Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 154
- Registration Number
- NCT02754596
- Locations
- 🇺🇸
John Berdahl, MD, Sioux Falls, South Dakota, United States
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
- Conditions
- Interventions
- First Posted Date
- 2014-12-30
- Last Posted Date
- 2022-12-22
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 91
- Registration Number
- NCT02327312
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
- Conditions
- Interventions
- First Posted Date
- 2013-10-31
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 92
- Registration Number
- NCT01972854
- Locations
- 🇺🇸
Focal Point Vision, San Antonio, Texas, United States
🇺🇸Gordon -Weiss Vision Institute, San Diego, California, United States
🇺🇸UPMC Eye Center, Pittsburgh, Pennsylvania, United States
Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism
- Conditions
- Interventions
- First Posted Date
- 2013-07-09
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 2
- Registration Number
- NCT01893359
- Locations
- 🇺🇸
Gordon -Weiss-Schanzlin Vision Institute, San Diego, California, United States
🇺🇸See Clearly Vision, McLean, Virginia, United States
🇺🇸Ophthalmic Consultants of Boston, Waltham, Massachusetts, United States
Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 191
- Registration Number
- NCT01841437
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
- Conditions
- Interventions
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 360
- Registration Number
- NCT01841450
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
- Conditions
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 108
- Registration Number
- NCT01836042
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
- Conditions
- Interventions
- First Posted Date
- 2012-07-18
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT01643226
- Locations
- 🇺🇸
Durrie Vision, Overland Park, Kansas, United States
🇺🇸Columbia University Harkness Eye Institute, New York, New York, United States
🇺🇸Cornea & Laser Eye Institute; Hersh Vision Group, Teaneck, New Jersey, United States